This study aimed to investigate the status of biomarker testing and prognosis in patients with post-operative recurrent non-small-cell lung cancer (NSCLC).
ESMO Open published a clinical update in Oncology on 31 Mar 2026.
The item focuses on Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L.
Review the original article for the full source wording and details.